...acetate, Recall # D-112-2009 CODE Lot: C75300 (exp July 2009) RECALLING FIRM/MANUFACTURER Recalling Firm: Wyeth Pharmaceuticals, Inc. Philadelphia PA, by letters dated November 20, 2008. Manufacturer: Wyeth Pharmaceuticals, Inc., Rouses Point NY. Firm initiated...

...Duensing, (Department of Microbiology and Molecular Genetics, University of Pittsburgh Medical School; Patrick Kelly (Wyeth Pharmaceuticals); David A. Williams (Division on Hematology/Oncology, Children's Hospital Boston, Harvard Medical School). Funding support...

...oncology and inflammation. To date, Catalyst has established two discovery research and product development agreements with Wyeth Pharmaceuticals and Centocor Research & Development, Inc. Catalyst is privately-held with backing by leading venture firms including Burrill...

...Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it has submitted a marketing authorization application to the European Medicines Agency for approval to market its investigational 13-valent pneumococcal conjugate vaccine (PCV13) for infants...

...LLC.; St. Jude Medical; the U.S. Department of Defense, Military Health System; the U.S. Department of Veterans Affairs; and Wyeth Pharmaceuticals. Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Brazil, Canada,...

...vs. 2.4%). RELISTOR full Prescribing Information for the U.S. is available at www.relistor.com. About the Companies Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal...